Cresanto Global Limited

Cresanto Global Limited, a player in the Pharmaceuticals & Biotechnology sector, has been assigned a Sell rating with a Mojo Score of 40.0, marking its first formal grade after previously being ungraded. This downgrade reflects a complex interplay of improved technical indicators contrasted by weak financial fundamentals and valuation concerns, prompting a cautious stance among investors.

Cresanto Global is rated Sell by MarketsMOJO, with this rating last updated on 12 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook.

Cresanto Global Limited, a player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high today, touching Rs.3.83. This milestone reflects notable momentum in the stock’s price movement amid a mixed market environment.

Cresanto Global Limited recorded a robust intraday performance today, reaching a new 52-week high of ₹3.83. The stock outpaced its sector and broader market indices, reflecting notable trading momentum within the Pharmaceuticals & Biotechnology industry.

Cresanto Global Limited witnessed extraordinary buying momentum on 25 Nov 2025, hitting its upper circuit with only buy orders in the queue. The stock’s performance today notably outpaced the broader market, reflecting a rare scenario of sustained demand without any sellers, signalling potential for a multi-day circuit lock.